Procter & Gamble Hygiene and Health Care Limited has informed the Exchange about Presentation
PGHH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
P&G Hygiene shared its investor and analyst presentation covering the 9-month fiscal year 2024-25 (July 2024 to March 2025), the result of a change in financial year-end from June to March. During this 9-month period, sales grew 3% and profit after tax (PAT) grew 7% compared to the same 9-month period last year. The company reported productivity savings of INR 93 crores for the year, driven by efficiencies in materials, manufacturing, ad spend, working capital, and overhead. The presentation highlighted a strong 10-year track record with net sales CAGR of 6%, PAT CAGR of 8%, and a 3x increase in ROE, along with over three decades of consistent dividend payouts. Strategic focus areas include portfolio brands like Whisper and Vicks, innovation pipeline, retail execution, and constructive disruption through AI/ML and supply chain digitization.
The results show steady, balanced growth and healthy productivity gains, which should reassure shareholders. However, the change in fiscal year to a 9-month transition period makes year-on-year comparison difficult, and the presentation mostly recaps past performance rather than offering fresh forward guidance, so the immediate stock reaction may be muted.